SARS-CoV-2 is not unique in its ability to cause post-acute sequelae; certain acute
infections have long been associated with an unexplained chronic disability in a minority of …

Background Post-acute coronavirus 2019 (COVID-19) syndrome is now recognized as a
complex systemic disease that is associated with substantial morbidity. Objectives To …

Background This study aims to examine the worldwide prevalence of post-coronavirus
disease 2019 (COVID-19) condition, through a systematic review and meta-analysis …

Importance Some individuals experience persistent symptoms after initial symptomatic
SARS-CoV-2 infection (often referred to as Long COVID). Objective To estimate the …

This review aimed to summarise the relative risk (RR) of the main symptoms of long COVID
in people infected with SARS-CoV-2 compared to uninfected controls, as well as the …

A considerable number of individuals infected with SARS-CoV-2 continue to experience
symptoms after the acute phase. Here, we report findings from a nationwide questionnaire …

Objective: To estimate by country and territory of the number of patients affected by long
COVID in 2020 and 2021, the severity of their symptoms and expected pattern of recovery …

Objective We characterized the evolution of neurologic symptoms and self‐perceived
recovery of non‐hospitalized COVID‐19 “long haulers” 6–9 months after their initial Neuro …

Background Long COVID occurs in those infected with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) whose symptoms persist or develop beyond the acute phase …

The World Health Organization (WHO) has recently created a clinical case definition to
frame a condition of symptom persistence following a coronavirus disease 2019 (COVID …